Double-blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palms
- PMID: 9155956
Double-blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palms
Abstract
We performed a randomized double-blind study within-group comparison in 11 patients to study the effect of subcutaneous injections of botulinum A toxin in focal hyperhidrosis of the palms. A total dose of 120 mU (mouse units) of botulinum A toxin (Dysport) was injected into six different sites on one palm, whereas the other was injected with sterile saline. Objective quantification of sweat production was performed using digitized ninhydrin-stained sheets. Three weeks after treatment, the mean reduction of sweat production in the botulinum A toxin-treated palms was 26% (P < 0.001), after 8 weeks 26% (P = 0.002) and after 13 weeks 31% (P < 0.001). Subjective assessment of sweat production by the patients using a visual analogue scale showed a 38% improvement in the botulinum A toxin-treated palms at 3 weeks (P = 0.002), 40% at 8 weeks (P = 0.002) and 38% at 13 weeks (P = 0.002). Neither the objective measurement nor the subjective rating showed a statistically significant reduction of sweating in the placebo-treated palms. Three patients reported reversible minor weakness of powerful handgrip after injection at the toxin-treated site, lasting between 2 and 5 weeks.
Comment in
-
Optimizing botulinum toxin therapy for hyperhidrosis.Br J Dermatol. 1998 Mar;138(3):553-4. doi: 10.1046/j.1365-2133.1998.02151.x. Br J Dermatol. 1998. PMID: 9580827 No abstract available.
Similar articles
-
Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study.Br J Dermatol. 2007 May;156(5):986-9. doi: 10.1111/j.1365-2133.2007.07760.x. Epub 2007 Feb 7. Br J Dermatol. 2007. PMID: 17286630 Clinical Trial.
-
Botulinum toxin A for axillary hyperhidrosis (excessive sweating).N Engl J Med. 2001 Feb 15;344(7):488-93. doi: 10.1056/NEJM200102153440704. N Engl J Med. 2001. PMID: 11172190 Clinical Trial.
-
Botulinum toxin type A therapy for palmar and digital hyperhidrosis.J Am Acad Dermatol. 2000 Jun;42(6):1026-9. J Am Acad Dermatol. 2000. PMID: 10827408 Clinical Trial.
-
[Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].Wien Klin Wochenschr. 2001;113 Suppl 4:20-4. Wien Klin Wochenschr. 2001. PMID: 15506048 Review. German.
-
[Type A botulinum toxin: a new methods in treating focal hyperhidrosis. A summary of various possibilities in hyperhidrosis therapy with special emphasis type A botulinum toxin injections].Praxis (Bern 1994). 2000 May 18;89(21):909-15. Praxis (Bern 1994). 2000. PMID: 10859980 Review. German.
Cited by
-
The treatment of primary palmar hyperhidrosis: a review.Surg Today. 2000;30(3):211-8. doi: 10.1007/s005950050047. Surg Today. 2000. PMID: 10752771 Review.
-
Botulinum toxin A injection for chronic anal fissures and anal sphincter spasm improves quality of life in recessive dystrophic epidermolysis bullosa.Int J Womens Dermatol. 2015 Oct 23;1(4):167-169. doi: 10.1016/j.ijwd.2015.08.002. eCollection 2015 Dec. Int J Womens Dermatol. 2015. PMID: 28491983 Free PMC article.
-
A systematic evidence-based review of treatments for primary hyperhidrosis.J Drug Assess. 2020 Dec 24;10(1):35-50. doi: 10.1080/21556660.2020.1857149. J Drug Assess. 2020. PMID: 33489435 Free PMC article.
-
Modification of blood vessel diameter following perivascular application of botulinum toxin-A.Hand (N Y). 2009 Sep;4(3):302-7. doi: 10.1007/s11552-009-9169-8. Epub 2009 Feb 5. Hand (N Y). 2009. PMID: 19194764 Free PMC article.
-
Evidence based medicine on the use of botulinum toxin for headache disorders.J Neural Transm (Vienna). 2008;115(4):647-51. doi: 10.1007/s00702-007-0832-3. Epub 2007 Nov 12. J Neural Transm (Vienna). 2008. PMID: 17994180 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials